On ECHEMI
Home > Drugs > Sichuan Nigale BIOTECHNOLOGY Co., Ltd.
Sichuan Nigale BIOTECHNOLOGY Co., Ltd.
  • Founded in:

    2013-06-08
  • Country:

    China China
  • Address:

    No. 28, Kuixing Road, Dongxi Town, Jianyang City
  • Tax NO.:

    91510185071405021T
  • Registered Funds:

    13.510795 yuan
  • Website:

  • Email:

Related Drugs
Red blood cell storage solution
Name Description Content CAS NO. Registered Holders
ALSEVER'S SOLUTION

0
Blood preservation solution Ⅲ
Name Description Content CAS NO. Registered Holders
Blood preservation solution Ⅲ

0
Blood preservation solution Ⅲ
Name Description Content CAS NO. Registered Holders
Blood preservation solution Ⅲ

0
Blood preservation solution (Ⅱ)
This product is a compound preparation, and its main components of 1000ml are: sodium citrate (C6H5O7Na3·2H2O) 22.0g, citric acid (C6H8O7·H2O) 8.0g, and glucose (C6H12O6·H2O) 24.5g.
Name Description Content CAS NO. Registered Holders
Trisodium citrate dihydrate

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing the calcium ions in the blood and inhibiting the coagulation process; at the same time, they form a buffer pair with citric acid to adjust and stabilize the pH of the solution.

More

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing the calcium ions in the blood and inhibiting the coagulation process; at the same time, they form a buffer pair with citric acid to adjust and stabilize the pH of the solution.

22.0g 6132-04-3 30
Citric acid monohydrate

It forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution; it participates in the anticoagulation mechanism.

More

It forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution; it participates in the anticoagulation mechanism.

8.0g 5949-29-1 38
GLUCOSE

It provides energy and osmotic pressure balance and has no direct anticoagulant effect.

More

It provides energy and osmotic pressure balance and has no direct anticoagulant effect.

24.5g 58367-01-4 14
Blood preservation solution (Ⅱ)
This product is a compound preparation, and its main components of 1000ml are: sodium citrate (C6H5O7Na3·2H2O) 22.0g, citric acid (C6H8O7·H2O) 8.0g, and glucose (C6H12O6·H2O) 24.5g.
Name Description Content CAS NO. Registered Holders
Trisodium citrate dihydrate

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing the calcium ions in the blood and inhibiting the coagulation process, thereby preventing blood from coagulating. Citric acid and sodium citrate form a buffer pair to adjust and stabilize the pH of the solution.

More

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing the calcium ions in the blood and inhibiting the coagulation process, thereby preventing blood from coagulating. Citric acid and sodium citrate form a buffer pair to adjust and stabilize the pH of the solution.

22.0g 6132-04-3 30
Citric acid monohydrate

Citric acid forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution.

More

Citric acid forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution.

8.0g 5949-29-1 38
GLUCOSE

This product is also known as ACD-A formula. Calcium is an essential substance in the coagulation process and can promote the formation of thrombin (coagulation factor III), thrombin and fibrin, as well as activate platelets to release coagulation factor reactions. The citrate ion of this product reacts with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate. This complex is easily soluble in water but not easy to dissociate, which reduces the calcium ions in the blood and inhibits the coagulation process, thereby preventing blood coagulation. Citric acid forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution. Sodium citrate is generally completely oxidized and metabolized in the tricarboxylic acid cycle, and its oxidation rate is close to the normal transfusion rate. The toxic dose of sodium citrate for healthy adults is about 15g, which is equivalent to 4000~5000ml of sodium citrate anticoagulant blood.

More

This product is also known as ACD-A formula. Calcium is an essential substance in the coagulation process and can promote the formation of thrombin (coagulation factor III), thrombin and fibrin, as well as activate platelets to release coagulation factor reactions. The citrate ion of this product reacts with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate. This complex is easily soluble in water but not easy to dissociate, which reduces the calcium ions in the blood and inhibits the coagulation process, thereby preventing blood coagulation. Citric acid forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution. Sodium citrate is generally completely oxidized and metabolized in the tricarboxylic acid cycle, and its oxidation rate is close to the normal transfusion rate. The toxic dose of sodium citrate for healthy adults is about 15g, which is equivalent to 4000~5000ml of sodium citrate anticoagulant blood.

24.5g 58367-01-4 14
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.